16 February 2022 | News
The programme will support the startup ecosystem, academia, new ventures, and biopharmaceutical projects
Bangalore Bioinnovation Centre (BBC) and Cytiva have agreed to work together to support the startup ecosystem and academia in the field of biopharmaceuticals by providing a platform for skill development and industry-oriented training in the field of bioprocessing (upstream, downstream and analytical characterisation).
The collaboration aligns well in giving impetus to the innovation ecosystem by driving industry-academia linkages and eventually, enhanced research.
Dr Jitendra, MD, Bangalore Bioinnovation Centre says, “This partnership will help to create a training program catering to the Biopharma Industry which is much needed today”.
Vaggu Raghavendra Goud, GM, Cytiva South Asia, says: “This collaboration enables us to bring our global knowledge and expertise to support BBC, local biotech companies and academia in fulfilling the need for skilled talent which will lead to improved efficiency, reduced time and cost of regional biopharma industry development.”
According to the Cytiva Biopharma Resilience Index, the talent pool is the weakest link in the global biopharma industry. 65% of Indian respondents in the Biopharma Resilience Index say that sourcing talent in technology, manufacturing, and R&D is a substantial challenge. Thus, the demand for the collaboration is expected to be high.